Paratus Clinical Research

17/07/2025

FACT or MYTH? Let’s talk about chlamydia.

It’s one of the most common STIs, and also one of the most misunderstood. Many people who have it don’t even know… and that’s exactly why regular testing is so important.

In today’s post, we’re busting some of the biggest myths and setting the facts straight. From how it spreads to what happens if it’s left untreated, we’ve got you covered.

👀 Swipe through to test your knowledge📍Tag a friend who needs to see this.

09/07/2025

🦠 You’ve probably heard the term RSV, but what exactly is it?

RSV (Respiratory Syncytial Virus) is a common and highly contagious virus that affects the lungs and respiratory tract. While it often causes mild, cold-like symptoms in healthy adults, it can be serious for:

👶 Infants
👵 Older adults
💉 Those with weakened immunity

RSV spreads easily through coughs, sneezes, and shared surfaces, and it’s one of the leading causes of hospitalisation in infants during the cooler months.

At Paratus Clinical, we're proud to support clinical research aimed at better understanding and preventing RSV, including vaccine and treatment development.

28/05/2025

📢 Exciting News 📢
We are thrilled to announce the launch of our new clinical research site in Northcote, Victoria! 🎉

💡 This state-of-the-art facility will expand access to psychiatric clinical research and primary care trials, providing innovative treatment opportunities for patients across Melbourne. With purpose-built rooms, this site is set to drive cutting-edge advancements in mental health and general medicine.

At Paratus Clinical, we are committed to advancing healthcare by connecting patients with groundbreaking clinical trials. This new site strengthens our ability to bridge the gap between research and patient care, working alongside leading institutions and industry partners.

💬 Interested in learning more about our research or participating in a trial? Visit www.paratusclinical.com for more details.

26/05/2025

https://region.com.au/a-norovirus-vaccine-might-be-on-the-cards-but-what-does-canberra-have-to-do-with-it/869360/

Check out Region Canberra's featured article on a trial we are conducting in the first mRNA norovirus vaccine, offering new hope in the fight against gastroenteritis. You can apply for similar studies at https://paratusclinical.com/register-vaccine

Canberrans have joined the battle to conquer gastroenteritis. Gastro, which inflames the stomach and intestines and can cause vomiting and…

16/05/2025

Did you know we run studies on weight loss and obesity!!
Clinical trials help develop treatments for various conditions. By participating in these studies, you can help us better understand how these treatments work and contribute to breakthroughs that improve lives.
Hit the link in our bio to join our database for future studies.

15/05/2025

Did you know we run studies on weight loss and skin cancer!!
Clinical trials help develop treatments for various conditions. By participating in these studies, you can help us better understand how these treatments work and contribute to breakthroughs that improve lives.
Sign up to our mailing list to stay updated on our latest studies & trials.

08/05/2025

Do you have a family history of cardiovascular disease?
We are looking for participants with raised lipoprotein (a), a type of cholesterol to help us evaluate if an investigational product could reduce cardiovascular events. Want to know if you’re eligible?
Apply now: https://paratusclinical.com/study-application-page-j3l-mc-ezef

Study Information:
This is a long term, phase 3, placebo-controlled clinical trial. If eligible, participants will attend at least 14 in clinic visits over approximately 4 years. At the clinic visits, participants will discuss the study with the doctor and clinic staff, and undergo physical examinations, blood tests, vital sign measurements and ECGs. These visits will include a fasted blood test and therefore will be booked in the morning.
The treatment will be given by subcutaneous injection once every 6 months for the first 1.5 years and then once a year until the end of the study. This study has a 1:1 ratio of treatment to placebo, which is randomly generated. You will not know which group you are in to prevent bias results.

06/05/2025

💡Lipoprotein(a) in the Spotlight!

We’re excited to share this 9News segment spotlighting breakthrough therapies that target Lipoprotein(a)—a genetic form of cholesterol linked to increased heart disease risk.

For those living with inherited cardiovascular risk, this could be a real game-changer. We’re watching this space with great interest 👀.

Curious about where cardiovascular research is headed? Reach out to our team today.

02/05/2025

❤️ Coming Up: Heart Week 2025

At Paratus Clinical, we’re proud to support Heart Week 2025 (5-11 May)—a time to shine a light on the importance of heart health and the steps we can all take to look after our hearts.

Did you know?
Heart disease is the leading cause of death in Australia, but most heart attacks are preventable with regular check-ups, healthy habits, and early treatment.

For Heart Week, we encourage everyone to:
✔ Book a heart health check with your GP
✔ Learn your blood pressure and cholesterol numbers
✔ Take time to manage stress and look after your mental health too

As a clinical trial site, we’re proud to be part of research that’s helping improve the way heart disease is diagnosed and treated. Thank you to our amazing participants who contribute to this work—you are making a difference.

💬 Interested in joining a clinical trial? Visit https://paratusclinical.com/register-cardiovascular to see the cardiovascular studies we are currently recruiting for! 🫀

16/04/2025

04/04/2025

✅ First participant enrolled— globally!

Paratus Clinical is proud to have welcomed the first participant worldwide into a new clinical study for a potential chlamydia vaccine. An exciting step toward making this common infection preventable!

👏 Huge thanks to our team and our first participant for helping push this important research forward.

01/04/2025

A new study at Paratus Clinical is testing the safety and effectiveness of an investigational vaccine in preventing chlamydia infections in young adults—find out more here https://paratusclinical.com/study-application-page-vav00023

Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or...